Literature DB >> 12116233

Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.

Takehiro Kobayashi1, Makoto Uchiyama, Shuhei Fukuro, Kiyoji Tanaka.   

Abstract

Xeroderma pigmentosum (XP) is a sun-sensitive and cancer-prone genetic disorder consisting of seven genetically distinct complementation groups (groups A-G). XP group D (XP-D) is a heterogeneous group. Mutations in the XPD gene (XPD) can exhibit three distinct clinical phenotypes: XP, trichothiodystrophy (TTD), or XP combined with Cockayne syndrome. XPD protein is required for both nucleotide excision repair (NER) and basal transcription. Therefore, different mutations in XPD may affect NER and transcription activities to various degrees and result in such diverse phenotypes. In this study, we identified six causative mutations, two of which have not been described, in five XP-D cell strains tested. The cell strains were all compound heterozygotes with different mutations. In all cell strains, one allele was thought to be functionally null and the other was a less severe allele with R683W, R683Q, and R666W substitutions. The second allele in each strain was specific to the XP phenotype. The findings are consistent with the hypothesis that the site of mutation of the XPD gene determines the clinical phenotype, XP or TTD. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116233     DOI: 10.1002/ajmg.10465

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.

Authors:  Jennifer Boyle; Takahiro Ueda; Kyu-Seon Oh; Kyoko Imoto; Deborah Tamura; Jared Jagdeo; Sikandar G Khan; Carine Nadem; John J Digiovanna; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2008-10       Impact factor: 4.878

2.  Differences in clinical phenotype among patients with XP complementation group D: 3D structure and ATP-docking of XPD in silico.

Authors:  Eiji Nakano; Ryusuke Ono; Taro Masaki; Seiji Takeuchi; Yutaka Takaoka; Eiichi Maeda; Chikako Nishigori
Journal:  J Invest Dermatol       Date:  2014-01-13       Impact factor: 8.551

3.  Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.

Authors:  Xiaolong Zhou; Sikandar G Khan; Deborah Tamura; Takahiro Ueda; Jennifer Boyle; Emmanuel Compe; Jean-Marc Egly; John J DiGiovanna; Kenneth H Kraemer
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

4.  Central osteosclerosis with trichothiodystrophy.

Authors:  Emma L Wakeling; Michele Cruwys; Mohnish Suri; Angela F Brady; Sarah E Aylett; Christine Hall
Journal:  Pediatr Radiol       Date:  2004-05-18

5.  Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients.

Authors:  Takahiro Ueda; Emmanuel Compe; Philippe Catez; Kenneth H Kraemer; Jean-Marc Egly
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

6.  Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.

Authors:  Hiva Fassihi; Mieran Sethi; Heather Fawcett; Jonathan Wing; Natalie Chandler; Shehla Mohammed; Emma Craythorne; Ana M S Morley; Rongxuan Lim; Sally Turner; Tanya Henshaw; Isabel Garrood; Paola Giunti; Tammy Hedderly; Adesoji Abiona; Harsha Naik; Gemma Harrop; David McGibbon; Nicolaas G J Jaspers; Elena Botta; Tiziana Nardo; Miria Stefanini; Antony R Young; Robert P E Sarkany; Alan R Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

7.  A novel nonsense mutation of ERCC2 in a Vietnamese family with xeroderma pigmentosum syndrome group D.

Authors:  Chi-Bao Bui; Thao Thi Phuong Duong; Vien The Tran; Thuy Thanh T Pham; Tung Vu; Gia Cac Chau; Thanh-Niem Van Vo; Vinh Nguyen; Dieu-Thuong Thi Trinh; Minh Van Hoang
Journal:  Hum Genome Var       Date:  2020-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.